|
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid |
|
CHEBI:137349 |
|
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid |
|
A dihydroxydocosahexaenoic acid that is (4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoic acid in which the two hydroxy substituents are located at the 14S- and 22-positions. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
Bijay
|
|
CHEBI:140254
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C22H32O4/c23-20-16-12-8-7-10-14-18-21(24)17-13-9-5-3-1-2-4-6-11-15-19-22(25)26/h1-2,5-6,8-14,17,21,23-24H,3-4,7,15-16,18-20H2,(H,25,26)/b2-1-,9-5-,11-6-,12-8-,14-10-,17-13+/t21-/m1/s1 |
OIAXNIJCPGIEPH-KBAXPYDNSA-N |
C(C(O)=O)C/C=C\C/C=C\C/C=C\C=C\[C@H](C/C=C\C/C=C\CCO)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
|
|
View more via ChEBI Ontology
Outgoing
|
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid
(CHEBI:137349)
has role
anti-inflammatory agent
(CHEBI:67079)
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid
(CHEBI:137349)
has role
human xenobiotic metabolite
(CHEBI:76967)
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid
(CHEBI:137349)
is a
ω-hydroxy-long-chain fatty acid
(CHEBI:140997)
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid
(CHEBI:137349)
is a
dihydroxydocosahexaenoic acid
(CHEBI:137348)
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid
(CHEBI:137349)
is a
secondary allylic alcohol
(CHEBI:134396)
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid
(CHEBI:137349)
is conjugate acid of
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoate
(CHEBI:136529)
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid
(CHEBI:137349)
is enantiomer of
(4Z,7Z,10Z,12E,14R,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid
(CHEBI:137350)
|
|
Incoming
|
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoate
(CHEBI:136529)
is conjugate base of
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid
(CHEBI:137349)
(4Z,7Z,10Z,12E,14R,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid
(CHEBI:137350)
is enantiomer of
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosahexaenoic acid
(CHEBI:137349)
|
(4Z,7Z,10Z,12E,14S,16Z,19Z)-14,22-dihydroxydocosa-4,7,10,12,16,19-hexaenoic acid
|
(14S,22)-diHDHA
|
ChEBI
|
(14S,22)-DiHDoHE
|
ChEBI
|
(14S,22)-dihydroxy-(4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoic acid
|
ChEBI
|
14(S),22-diHDHA
|
SUBMITTER
|
14(S),22-dihydroxydocosahexaenoic acid
|
ChEBI
|
MaR-L1
|
SUBMITTER
|
maresin-L1
|
ChEBI
|
27627499
|
Reaxys Registry Number
|
Reaxys
|
25200603
|
PubMed citation
|
Europe PMC
|
|